{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:00:17Z","timestamp":1790136017969,"version":"4.0.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundition of science and technology commission of Jilin Province","award":["No. 20190201065JC"],"award-info":[{"award-number":["No. 20190201065JC"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Hereditary hemochromatosis (HH) is a frequent autosomal recessive disease. The pathogenesis of disease is excessive intestinal absorption of dietary iron, resulting in pathologically high iron storage in tissues and organs. As a systemic disease, it has several manifestations including cirrhosis, diabetes mellitus, cardiomyopathy, joint disease. However, a proportion of patients are asymptomatic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 34-year-old man who had abnormal liver function for 9 months without specific symptoms. He underwent various tests, including liver biopsy and genetic testing, which eventually ruled out common liver diseases and identified iron metabolic abnormalities. In addition, we confirmed the pathogenic genes by sequencing the genes of him and his families.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Combined with the symptoms, auxiliary examinations and sequencing results, the patient was diagnosed as HH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was given a low iron diet and phlebotomy therapy interval 2 weeks until the ferritin is &lt;100\u200amg\/L.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient\u2019 condition is stable during the follow-up period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>When clinicians are confronted with unexplained liver dysfunction, the possibility of the HH should be considered. Liver biopsy and gene sequencing are helpful in diagnosis. Phlebotomy treatment is the most economical and practical treatment for HH at present, but it should vary from person to person.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017526","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T19:38:47Z","timestamp":1572896327000},"page":"e17526","source":"Crossref","is-referenced-by-count":5,"title":["A case report of hereditary hemochromatosis caused by mutation of SLC40A1 gene"],"prefix":"10.1097","volume":"98","author":[{"given":"Xin","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Digestive disease, Tai\u2019an Municipal Hospital, Tai\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-long","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cld.2014.09.011","article-title":"Diagnosis and management of hereditary hemochromatosis","volume":"19","author":"Salgia","year":"2015","journal-title":"Clin Liver Dis"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12185-017-2365-3","article-title":"The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis","volume":"107","author":"Kawabata","year":"2018","journal-title":"Int J Hematol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/B:EJEP.0000017664.96394.b9","article-title":"Is genetic screening for hemochromatosis worthwhile","volume":"19","author":"Njajou","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jmedgenet-2018-105348","article-title":"Non-HFE mutations in haemochromatosis in China: combination of heterozygous mutations involving HJV signal peptide variants","volume":"55","author":"Lv","year":"2018","journal-title":"J Med Genet"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2036.2012.05051.x","article-title":"The iron overload syndromes","volume":"35","author":"Siddique","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"CR622","DOI":"10.12659\/MSM.883489","article-title":"Iranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutations","volume":"18","author":"Zamani","year":"2012","journal-title":"Med Sci Monit"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/jgh.12222","article-title":"Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutations","volume":"28","author":"Mcdonald","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12072-015-9608-2","article-title":"Recent advances in hemochromatosis: a 2015 update","volume":"9","author":"Ekanayake","year":"2015","journal-title":"Hepatol Int"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAT.0b013e3283490e04","article-title":"The changing role of liver biopsy in diagnosis and management of haemochromatosis","volume":"43","author":"Bassett","year":"2011","journal-title":"Pathology"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2015.11.009","article-title":"Iron metabolism and related genetic diseases: a cleared land, keeping mysteries","volume":"64","author":"Brissot","year":"2016","journal-title":"J Hepatol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/BJ20051682","article-title":"Wild-type and mutant ferroportins do not form oligomers in transfected cells","volume":"396","author":"Goncalves","year":"2006","journal-title":"Biochem J"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bjh.14376","article-title":"How we manage patients with hereditary haemochromatosis","volume":"175","author":"Rombout-Sestrienkova","year":"2016","journal-title":"Br J Haematol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fphar.2016.00160","article-title":"Pharmacological targeting of the hepcidin\/ferroportin axis","volume":"7","author":"Sebastiani","year":"2016","journal-title":"Front Pharmacol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/90038","article-title":"A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis","volume":"28","author":"Njajou","year":"2001","journal-title":"Nat Genet"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1053\/gast.2001.24033","article-title":"Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload","volume":"120","author":"Zoller","year":"2001","journal-title":"Gastroenterology"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000112830","article-title":"SLC40A1 c.1402G\u2013a result in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype","volume":"118","author":"Lee","year":"2007","journal-title":"Acta Haematol"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2141.2005.05815.x","article-title":"Genetic and clinical heterogeneity of ferroportin disease","volume":"131","author":"Cemonesi","year":"2005","journal-title":"Br J Haematol"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"1199.e2","DOI":"10.1053\/j.gastro.2010.12.049","article-title":"Sex and acquired cofactors determine phenotypes of ferroportin disease","volume":"140","author":"Le Lan","year":"2011","journal-title":"Gastroenterology"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2015.140","article-title":"The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data","volume":"18","author":"Wallace","year":"2016","journal-title":"Genet Med"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2010.05.016","article-title":"Ferroportin disease: a systematic meta-analysis of clinical and molecular findings","volume":"53","author":"Mayr","year":"2010","journal-title":"J Hepatol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/liv.14013","article-title":"A novel SLC40A1 p. Y333H mutation with gain of function of ferroportin: a recurrent cause of haemochromatosis in China","volume":"39","author":"Zhang","year":"2019","journal-title":"Liver Int"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3324\/haematol.2018.189845","article-title":"The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism","volume":"103","author":"Ka","year":"2018","journal-title":"Haematologica"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1399-0004.2006.00644.x","article-title":"Ferroportin (SLC40A1) gene in thalassemic patients of Indian descent","volume":"70","author":"Agarwal","year":"2006","journal-title":"Clin Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:41:08Z","timestamp":1694824868000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":23,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017526","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}